Saturday, July 11, 2026

ABL Bio to Invest Additional $25 Million in Neok Bio to Accelerate ADC Clinical Trials

ABL Bio invests $25M in Neok Bio for bispecific antibody-drug conjugate trials, aiming for FDA-approved treatments by 2027.

Why is Kim Jong Un’s Birthday on January 8th Still a Mystery?

On Kim Jong Un's reported birthday, North Korean media remained silent, contrasting with celebrations for his predecessors.

NHN’s Agentic Day: How AI Agents Are Transforming Business Efficiency in 2026

NHN hosted Agentic Day to promote AI integration, showcasing employee innovations and emphasizing secure AI-driven growth strategies.

Tag: HIV treatment

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

How ‘Sunlenkaju’ and ‘Sunlenkajeong’ Are Revolutionizing HIV-1 Therapy in 2026

FDA approves lenacapavir-based HIV treatments for patients with multidrug-resistant infections, enhancing options for difficult cases.

Long-Acting HIV Treatment Vocabria + Rekambys Offers New Hope with Just Six Injections a Year

Long-acting HIV treatment Vocabria + Rekambys improves adherence and quality of life, reducing daily pill burden to six injections yearly.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.